{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:03:17Z","timestamp":1789783397260,"version":"4.0.1"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This investigation assessed the clinical characteristics of patients who received care through telemedicine and the clinical impact telemedicine service had on breast cancer patients in a low-income country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This natural experimental study assessed the impact of telemedicine service on cancer outcomes among breast cancer patients at Shaukat Khanum Memorial Trust (SKMT), Pakistan, between January 1st, 2018, to December 31st, 2022. The study group (hybrid group) consisted of patients that had both face-to-face and telemedicine appointments, and the control group (physical group) included patients with only face-to-face encounters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,205 patients were included in the analysis. Among those included in the analysis, 3,188 (99.5 %) were females, and the mean age of the cohort was 48.10 \u00b1 11.94 years. Statistically significant differences were observed between the two groups in age, demographic distribution, disease stage, average number of emergency room visits, mean length of stay in the Intensive care unit, and the final patient status (alive at the end of observation period). However, the binary logistic regression model (forward-LR) suggested that the final patient outcome was related to disease relapse, COVID-19 infection, and age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Telemedicine clinics, when conducted in parallel with physical clinics (hybrid setup), are safe and have a clinical impact similar to having just physical encounters among breast cancer patients in a low-income country.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.37029\/jcas.v10i2.679","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T19:43:57Z","timestamp":1723837437000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Using Telemedicine to Care for Patients with Breast Cancer: A Natural Quasi-Experimental Study"],"prefix":"10.2478","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-9587","authenticated-orcid":false,"given":"Khawaja Shehryar","family":"Nasir","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre , Lahore , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-1959","authenticated-orcid":false,"given":"Farhana","family":"Badar","sequence":"additional","affiliation":[{"name":"Department of Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre , Lahore , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-2746","authenticated-orcid":false,"given":"Muhammad Aasim","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre , Lahore , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"2026091901455588609_j_jcas.v10i2.679_ref_001","doi-asserted-by":"crossref","unstructured":"Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 2018;38:540-5.","DOI":"10.1200\/EDBK_200141"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_002","doi-asserted-by":"crossref","unstructured":"Royce TJ, Sanoff HK, Rewari A. Telemedicine for cancer care in the time of COVID-19. JAMA Oncol 2020;6:1698-9.","DOI":"10.1001\/jamaoncol.2020.2684"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_003","doi-asserted-by":"crossref","unstructured":"Yadav K, Ginsburg O, Basu P, Mehrotra R. Telemedicine and cancer care in low-and middle-income countries during the SARS-CoV-2 pandemic. JCO Glob Oncol 2021;7:1633-8.","DOI":"10.1200\/GO.21.00249"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_004","doi-asserted-by":"crossref","unstructured":"Gondal H, Abbas T, Choquette H, Le D, Chalchal HI, Iqbal N, et al. Patient and physician satisfaction with telemedicine in cancer care in Saskatchewan: A cross-sectional study. Curr Oncol 2022;29:3870-80.","DOI":"10.3390\/curroncol29060309"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_005","doi-asserted-by":"crossref","unstructured":"Roque K, Ruiz R, Otoya-Fernandez I, Galarreta J, Vidaurre T, de Mello RA, et al. The impact of telemedicine on cancer care: Real-world experience from a Peruvian institute during the COVID-19 pandemic. Future Oncol 2022;18:3501-8.","DOI":"10.2217\/fon-2022-0239"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_006","doi-asserted-by":"crossref","unstructured":"Novara G, Checcucci E, Crestani A, Abrate A, Esperto F, Pavan N, et al. Telehealth in urology: A systematic review of the literature. How much can telemedicine be useful during and after the COVID-19 pandemic? Eur Urol 2020;78:786-811.","DOI":"10.1016\/j.eururo.2020.06.025"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_007","doi-asserted-by":"crossref","unstructured":"Panet F, T\u00e9treault-Langlois M, Morin V, Sultanem K, Melnychuk D, Panasci L. The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature. Cancer Rep (Hoboken) 2022;5:e1531.","DOI":"10.1002\/cnr2.1531"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_008","doi-asserted-by":"crossref","unstructured":"Edge SB, Compton CC. The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.","DOI":"10.1245\/s10434-010-0985-4"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_009","doi-asserted-by":"crossref","unstructured":"Bidoli E, Virdone S, Hamdi-Cherif M, Toffolutti F, Taborelli M, Panato C, et al. Worldwide age at onset of female breast cancer: A 25-year population-based cancer registry study. Sci Rep 2019;9:14111.","DOI":"10.1038\/s41598-019-50680-5"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_010","doi-asserted-by":"crossref","unstructured":"Satagopan JM, Stroup A, Kinney AY, Dharamdasani T, Ganesan S, Bandera EV. Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study. Int J Cancer 2021;148:1598-607.","DOI":"10.1002\/ijc.33331"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_011","doi-asserted-by":"crossref","unstructured":"Alrahawy M, Johnson C, Aker M, Eltyeb HA, Green S. Impact of COVID-19 on the mode of presentation and stage at diagnosis of colorectal cancer. Cureus 2022;14:e32037.","DOI":"10.7759\/cureus.32037"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_012","doi-asserted-by":"crossref","unstructured":"\u0130lg\u00fcn AS, \u00d6zmen V. The impact of the COVID-19 pandemic on breast cancer patients. Eur J Breast Health 2022;18:85-90.","DOI":"10.4274\/ejbh.galenos.2021.2021-11-5"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_013","doi-asserted-by":"crossref","unstructured":"Nyante SJ, Benefield TS, Kuzmiak CM, Earnhardt K, Pritchard M, Henderson LM. Population\u2010level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures. Cancer 2021;127:2111-21.","DOI":"10.1002\/cncr.33460"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_014","doi-asserted-by":"crossref","unstructured":"Miller MM, Meneveau MO, Rochman CM, Schroen AT, Lattimore CM, Gaspard PA, et al. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat 2021;189:237-46.","DOI":"10.1007\/s10549-021-06252-1"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_015","doi-asserted-by":"crossref","unstructured":"Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: Between threats and opportunities. Future Oncol 2020;16:1225-7.","DOI":"10.2217\/fon-2020-0324"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_016","unstructured":"Shirke MM, Shaikh SA, Harky A. Implications of telemedicine in oncology during the COVID-19 pandemic. Acta Biomed 2020;91:e2020022."},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_017","doi-asserted-by":"crossref","unstructured":"Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, et al. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer 2022;127:558-68.","DOI":"10.1038\/s41416-022-01830-6"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_018","doi-asserted-by":"crossref","unstructured":"Zhou Y, Yang Q, Ye J, Wu X, Hou X, Feng Y, et al. Clinical features and death risk factors in COVID-19 patients with cancer: A retrospective study. BMC Infect Dis 2021;21:760.","DOI":"10.1186\/s12879-021-06495-9"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_019","doi-asserted-by":"crossref","unstructured":"Lafourcade A, His M, Baglietto L, Boutron-Ruault MC, Dossus L, Rondeau V. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: The French E3N cohort. BMC Cancer 2018;18:171.","DOI":"10.1186\/s12885-018-4076-4"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_020","doi-asserted-by":"crossref","unstructured":"Mauguen A, Rachet B, Mathoulin-P\u00e9lissier S, Lawrence GM, Siesling S, MacGrogan G, et al. Validation of death prediction after breast cancer relapses using joint models. BMC Med Res Methodol 2015;15:27.","DOI":"10.1186\/s12874-015-0018-x"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_021","doi-asserted-by":"crossref","unstructured":"Dent R, Valentini A, Hanna W, Rawlinson E, Rakovitch E, Sun P, et al. Factors associated with breast cancer mortality after local recurrence. Curr Oncol 2014;21:e418-25.","DOI":"10.3747\/co.21.1563"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_022","doi-asserted-by":"crossref","unstructured":"San Miguel Y, Gomez SL, Murphy JD, Schwab RB, McDaniels-Davidson C, Canchola AJ, et al. Age-related differences in breast cancer mortality according to race\/ethnicity, insurance, and socioeconomic status. BMC Cancer 2020;20:228.","DOI":"10.1186\/s12885-020-6696-8"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_023","doi-asserted-by":"crossref","unstructured":"Vatansev H, Kadiyoran C, Cumhur Cure M, Cure E. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. Med Hypotheses 2020;143:110091.","DOI":"10.1016\/j.mehy.2020.110091"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_024","doi-asserted-by":"crossref","unstructured":"Bhatti AB, Jamshed A, Shah M, Khan A. Breast conservative therapy in Pakistani women: Prognostic factors for locoregional recurrence and overall survival. J Cancer Res Ther 2015;11:300-4.","DOI":"10.4103\/0973-1482.140828"},{"key":"2026091901455588609_j_jcas.v10i2.679_ref_025","doi-asserted-by":"crossref","unstructured":"Leatherdale ST. Natural experiment methodology for research: A review of how different methods can support real-world research. Int J Soc Res Methodol 2019;22:19-35.","DOI":"10.1080\/13645579.2018.1488449"}],"container-title":["Journal of Cancer and Allied Specialties"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sfu.ca\/jcas\/index.php\/jcas\/article\/download\/679\/513","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.37029\/jcas.v10i2.679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:46:11Z","timestamp":1789782371000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.37029\/jcas.v10i2.679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8,16]]},"published-print":{"date-parts":[[2024,8,1]]}},"alternative-id":["10.37029\/jcas.v10i2.679"],"URL":"https:\/\/doi.org\/10.37029\/jcas.v10i2.679","relation":{},"ISSN":["2411-989X"],"issn-type":[{"value":"2411-989X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}